Cardiosense
Cardiosense provides clinicians and researchers with early detection of cardiac disease by extracting predictive biomarkers from physiological waveforms. The company combines novel multi-modal sensors and multi-sensor devices with advanced signal-processing pipelines and AI-driven algorithms to mine raw biosignals for pre-symptomatic markers. Cardiosense operates as a digital biomarker platform / MedTech solution that pairs hardware sensors with proprietary software for biomarker development and personalized therapy enablement. Its technology is aimed at healthcare providers, clinical researchers, and life‑science partners working on cardiac disease detection and treatment.
Cardiosense
Cardiosense provides clinicians and researchers with early detection of cardiac disease by extracting predictive biomarkers from physiological waveforms. The company combines novel multi-modal sensors and multi-sensor devices with advanced signal-processing pipelines and AI-driven algorithms to mine raw biosignals for pre-symptomatic markers. Cardiosense operates as a digital biomarker platform / MedTech solution that pairs hardware sensors with proprietary software for biomarker development and personalized therapy enablement. Its technology is aimed at healthcare providers, clinical researchers, and life‑science partners working on cardiac disease detection and treatment.
